Literature DB >> 25081508

Serum inflammatory markers for periprosthetic knee infection in obese versus non-obese patients.

Jane Z Liu1, Anas Saleh2, Alison K Klika2, Wael K Barsoum2, Carlos A Higuera2.   

Abstract

Accurate diagnosis of periprosthetic joint infection (PJI) is challenging. Most infection diagnosis criteria define elevated serum C-reactive protein (CRP) as >1.0mg/dL and erythrocyte sedimentation rate (ESR) as >30mm/hour. Obesity has been reported as a pro-inflammatory state with elevated baseline CRP values. We hypothesized that higher cut-off values would be more accurate to diagnose PJI in obese patients due to their elevated baseline CRP. BMI, serum inflammatory markers, and synovial fluid were collected for 102 revision total knee arthroplasty patients, and analyzed for the highest area under the curve. We found a CRP of 3.6mg/dL was more accurate to diagnose PJI in obese patients versus traditional values. Clinicians should be judicious and use additional criteria when diagnosing PJI in obese patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C-reactive protein; diagnosis; obesity; periprosthetic infection; total knee arthroplasty

Mesh:

Substances:

Year:  2014        PMID: 25081508     DOI: 10.1016/j.arth.2014.07.005

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

Review 1.  Diagnosis of peripheral bone and prosthetic joint infections: overview on the consensus documents by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Luca Maria Sconfienza; Alberto Signore; Victor Cassar-Pullicino; Maria Adriana Cataldo; Olivier Gheysens; Olivier Borens; Andrej Trampuz; Klaus Wörtler; Nicola Petrosillo; Heinz Winkler; Filip M H M Vanhoenacker; Paul C Jutte; Andor W J M Glaudemans
Journal:  Eur Radiol       Date:  2019-06-27       Impact factor: 5.315

2.  Evaluation of serum levels of C-reactive protein after total knee arthroplasty.

Authors:  João Maurício Barretto; Fabrício Bolpato Loures; Rodrigo Sattamini Pires E Albuquerque; Filipe das Neves Bezerra; Rafael Vinagre Faro; Naasson Trindade Cavanellas
Journal:  Rev Bras Ortop       Date:  2017-03-06

3.  Serum biomarkers in periprosthetic joint infections.

Authors:  A Saleh; J George; M Faour; A K Klika; C A Higuera
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

4.  Plasma fibrinogen in the diagnosis of periprosthetic joint infection.

Authors:  Fei Yang; Chenyu Zhao; Rong Huang; Hui Ma; Xiaohe Wang; Guodong Wang; Xiaowei Zhao
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Albumin to Globulin ratio, Neutrophil to Lymphocyte ratio, and Globulin levels do not outperform ESR or CRP when diagnosing periprosthetic joint infection.

Authors:  Jing-Bo Jiao; Jin-Cheng Huang; Xiao Chen; Yi Jin
Journal:  BMC Musculoskelet Disord       Date:  2022-04-30       Impact factor: 2.362

6.  Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).

Authors:  Alberto Signore; Luca Maria Sconfienza; Olivier Borens; Andor W J M Glaudemans; Victor Cassar-Pullicino; Andrej Trampuz; Heinz Winkler; Olivier Gheysens; Filip M H M Vanhoenacker; Nicola Petrosillo; Paul C Jutte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-26       Impact factor: 9.236

7.  Serum globulin and albumin to globulin ratio as potential diagnostic biomarkers for periprosthetic joint infection: a retrospective review.

Authors:  Yongyu Ye; Weishen Chen; Minghui Gu; Guoyan Xian; Baiqi Pan; Linli Zheng; Ziji Zhang; Puyi Sheng
Journal:  J Orthop Surg Res       Date:  2020-10-07       Impact factor: 2.359

8.  Synovial Complement Factors in Patients with Periprosthetic Joint Infection after Undergoing Revision Arthroplasty of the Hip or Knee Joint.

Authors:  Frank Sebastian Fröschen; Sophia Schell; Matthias Dominik Wimmer; Gunnar Thorben Rembert Hischebeth; Hendrik Kohlhof; Sascha Gravius; Thomas Martin Randau
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.